Form 144: 7,988 TRDA RSUs Listed for Sale

Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 relating to TRDA securities, showing 7,988 restricted stock units listed to be sold by the broker/issuer role on 03/01/2026.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 relating to TRDA securities, showing 7,988 restricted stock units listed to be sold by the broker/issuer role on 03/01/2026. The filing also reports recent dispositions by Kory Wentworth of 5,712 and 2,939 common shares on 03/03/2026 and 03/02/2026, respectively, with reported proceeds of $67,152.56 and $34,262.57.

Insights

Compliance Analyst

Routine Form 144 sale notification showing small, reported dispositions.

The filing lists 7,988 restricted stock units to be sold by the broker/issuer entry dated 03/01/2026 and two recent sales by Kory Wentworth of 5,712 and 2,939 shares on 03/03/2026 and 03/02/2026. Reported proceeds are $67,152.56 and $34,262.57.

These entries appear procedural and consistent with Form 144 reporting requirements; cash‑flow treatment and whether sales were via block trades or market transactions are not specified in the excerpt. Subsequent filings or broker confirmations may provide execution details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does TRDA's Form 144 show about shares offered for sale?

The filing lists 7,988 restricted stock units dated 03/01/2026 as securities to be sold. It also reports two recent common‑share dispositions by Kory Wentworth on 03/02/2026 and 03/03/2026.

How many shares did Kory Wentworth report selling in March 2026 for TRDA?

Kory Wentworth reported selling 2,939 shares on 03/02/2026 and 5,712 shares on 03/03/2026. The filing lists the two transactions separately with their dates and amounts.

What proceeds were reported for the recent TRDA sales?

The reported proceeds are $34,262.57 for the 2,939‑share sale on 03/02/2026 and $67,152.56 for the 5,712‑share sale on 03/03/2026. These figures appear in the Form 144 excerpt.

Who is listed as the filer and broker on the TRDA Form 144?

The filer/broker is shown as Morgan Stanley Smith Barney LLC Executive Financial Services with an address at 1 New York Plaza, 8th Floor, New York, NY. That entity appears on the securities rows in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 05:11 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001725663
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ENTRADA THERAPEUTICS INC
SEC File Number	001-40969
Address of Issuer	One Design Center Place, Suite 17-500 Boston MASSACHUSETTS 02210
Phone	8575209158
Name of Person for Whose Account the Securities are To Be Sold	KORY WENTWORTH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7988	94657.80	38284313	03/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2026	Restricted Stock Units	Issuer			7988	03/01/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KORY WENTWORTH One Design Center Place, Suite 17-500 Boston MA 02210	Common	03/03/2026	5712	67152.56
KORY WENTWORTH One Design Center Place, Suite 17-500 Boston MA 02210	Common	03/02/2026	2939	34262.57

144: Remarks and Signature

Remarks
Date of Notice	03/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kory Wentworth
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)